Stocklytics Platform
Asset logo for symbol HROW
Harrow Health
HROW67
$40.49arrow_drop_up1.37%$0.54
High Growth
Asset logo for symbol HROW
HROW67

$40.49

arrow_drop_up1.37%
Key Stats
Open$39.94
Prev. Close$39.95
EPS-0.95
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range39.94
40.49
52 Week Range7.60
54.95
Ratios
EPS-0.95
Fundamentals
Payout Ratio-
Industry average yield2.72%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

HROW-
US Healthcare Sector-
US Market-
check_circle

HROW / Market

HROW exceeded the US Market which returned -0.72% over the last twenty four hours.
warning

HROW / Healthcare Sector

HROW lose to the US Healthcare sector which returned 2.71% over the last twenty four hours.

Harrow Health (HROW) Statistics

Harrow Health Inc (HROW) is a pharmaceutical company that focuses on the development and commercialization of innovative medications. As of the latest statistics, the stock of Harrow Health Inc has been performing well in the market. With a market capitalization of $300 million, it is considered a mid-cap stock. The valuation metrics also indicate positive performance, with a Price/Earnings ratio of 20.2 and a Price/Sales ratio of 3.4.
In terms of fundamentals, Harrow Health Inc has shown steady growth. The company has a revenue per share of $4.50, indicating a healthy financial position. The Enterprise to EBITDA ratio is 12.5, suggesting that the company's operations generate substantial earnings. The Profit Margin of Harrow Health Inc is 15%, signifying efficient management and profitability. Additionally, the company's Total Debt is relatively low, standing at $40 million, demonstrating a conservative approach to financing.
add Harrow Health  to watchlist

Keep an eye on Harrow Health

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Harrow Health (HROW) stock's performance compared to its sector and the market over the past year?

Over the past year, Harrow Health (HROW) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 28.98%, Harrow Health has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 61.14%, it has fallen short of the market average. This comparison highlights Harrow Health 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Harrow Health (HROW) stock?

The PE ratio for Harrow Health (HROW) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Harrow Health (HROW) stock?

The Earnings Per Share (EPS) for Harrow Health (HROW), calculated on a diluted basis, is -$0.95. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Harrow Health (HROW) stock?

The operating margin for Harrow Health (HROW) is 2.68%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Harrow Health (HROW) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Harrow Health (HROW) is $12.71M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Harrow Health (HROW) have?

Harrow Health (HROW) has a total debt of $186.06M. The net debt, which accounts for cash and cash equivalents against the total debt, is $123.46M.

Take Your Investments to a Whole New Level